The DOI matches its Crossref record.
Mechanisms of Cataract Formation in the Human Lens
Open accessAbstract
Background Brolucizumab has recently been approved in Europe as a novel treatment for patients with neovascular age-related macular degeneration (nAMD). We report on early experiences with real-world outcomes of switch to brolucizumab therapy in previously anti-vascular endothelial growth factor (anti-VEGF)-treated patients. Methods Patients with recalcitrant nAMD were switched to brolucizumab therapy. Functional and structural parameters 4 weeks after first brolucizumab injection were evaluated including best-corrected visual acuity (BCVA (logMAR)), foveal centre point (FCP (µm)), central subfield retinal thickness (CSRT (µm)) and macular volume (mm³). Results Sixty-three eyes of 57 patients with nAMD (52.6% females) with a mean (±SD) age of 79.5±6.7 years were included. Mean change of BCVA was −0.02±0.13 logMAR (p=0.322). Significant reductions were recorded for FCP with a mean (±SD) change of −66.79±72.64 µm, −66.76±60.71 µm for CSRT and −0.27±0.24 mm³ for macular volume (all p<0.001). Intraocular inflammation was observed in seven eyes of seven patients, including one case of retinal vasculitis without occlusion. Conclusions The results of the SHIFT study indicate that switch to brolucizumab may represent a treatment option in patients with nAMD poorly responsive to other anti-VEGF agents. Further long-term analyses appear prudent to assess efficacy and safety of brolucizumab in a routine clinical setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Age-related nuclear cataract—oxidation is the key
Truscott, R. J. W. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2004.12.007 · Cited by 857
The ageing lens and cataract: a model of normal and pathological ageing
Michael, R., & Bron, A. J. (2011) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2010.0300 · Cited by 486
Lou, M. F. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(03)00050-8 · Cited by 421
Is blindsight an effect of scattered light, spared cortex, and near-threshold vision?
Campion, J., Latto, R., & Smith, Y. M. (1983) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00016861 · Cited by 413
Groenen, P. J. T. A., Merck, K. B., De Jong, W. W., & Bloemendal, H. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00001.x · Cited by 376
Epidemiology of risk factors for age-related cataract
Seddon, J., Fong, D., West, S. K., & Valmadrid, C. T. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80110-9 · Cited by 357
The Lens: Development, Proteins, Metabolism and Cataract
HARDING, J. J., & CRABBE, M. J. C. (1984) · The Eye · doi:10.1016/b978-0-12-206921-5.50008-8 · Cited by 345
X-ray analysis of the eye lens protein γ-II crystallin at 1·9 Å resolution
Wistow, G., Turnell, B., Summers, L., Slingsby, C., Moss, D., Miller, L., Lindley, P., & Blundell, T. (1983) · Journal of Molecular Biology · doi:10.1016/s0022-2836(83)80232-0 · Cited by 299
An update on the role of free radicals and antioxidant defense in human disease
Vendemiale, G., Grattagliano, I., & Altomare, E. (1999) · International Journal of Clinical & Laboratory Research · doi:10.1007/s005990050063 · Cited by 269
Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention
Jacques, P., & Chylack, L. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.1.352s · Cited by 262
The post-mortem preservation of the transmissivity of the human crystalline lens
Weale, R. A. (1985) · Experimental Eye Research · doi:10.1016/0014-4835(85)90037-5 · Cited by 12
Metadata
- Authors
- Fisher, R. F.
- Venue
- British Journal of Ophthalmology
- Publisher
- BMJ
- Published
- 1981-11-01
- Volume
- 65
- Issue
- 11
- Pages
- 804-804
- ISSN
- 0007-1161 (ISSN-L)
- OpenAlex
- W2063749576
- Cited by
- 237
- References
- 0
- FWCI
- 41.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.